Cristina L. Fajardo-Davila
Granada, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Functional in vitro assessment of the HER2 Ile655Val variant on trastuzumab-induced cardiotoxicity in human cardiomyocytes.
Journal: European journal of pharmacology
Published: September 17, 2025
Custom Gene Panel Analysis Identifies Novel Polymorphisms Associated with Clopidogrel Response in Patients Undergoing Percutaneous Coronary Intervention with Stent.
Journal: International journal of molecular sciences
Published: August 21, 2025
Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study.
Journal: EClinicalMedicine
Published: June 05, 2025
A model including CD15, ACE2 and age efficiently predicts COVID-19 severity.
Journal: Scientific reports
Published: November 26, 2024
Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE Study.
Journal: Clinical pharmacology and therapeutics
Published: September 19, 2024
Targeted next-generation sequencing panel to investigate antiplatelet adverse reactions in acute coronary syndrome patients undergoing percutaneous coronary intervention with stenting.
Journal: Thrombosis research
Published: March 07, 2024
Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 21, 2023
Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study.
Journal: Human genomics
Published: April 16, 2023
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
Journal: Lancet (London, England)
Published: July 18, 2022
Genetic Polymorphisms in VEGFR Coding Genes (FLT1/KDR) on Ranibizumab Response in High Myopia and Choroidal Neovascularization Patients.
Journal: Pharmaceutics
Published: June 20, 2022
Genetic Polymorphisms Affecting Ranibizumab Response in High Myopia Patients.
Journal: Pharmaceutics
Published: September 08, 2021
Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries.
Journal: PloS one
Published: August 04, 2021
Last Updated: 09/26/2026